Results 91 to 100 of about 58,247 (201)
Purpose. This study aimed to evaluate the clinical efficacy of using expression levels of CCL24 (eotaxin-2) mRNA on the ocular surface as a biomarker in patients with vernal keratoconjunctivitis (VKC) and atopic keratoconjunctivitis (AKC).
Yukiko Shiraki, Jun Shoji, Noriko Inada
doaj +1 more source
Background: This study investigated the histamine H1 and H4 receptors mRNA (H1R and H4R, respectively) expression on the ocular surface of patients with chronic forms of allergic conjunctival diseases to determine whether they can serve as biomarkers for
Noriko Inada +4 more
doaj +1 more source
Analysis of the Conjunctival Microbiome in Patients with Atopic Keratoconjunctivitis and Healthy Individuals. [PDF]
Hur MS, Lee JS, Jang M, Shin HJ, Lee YW.
europepmc +1 more source
Objective: To know the demography and clinical profile of patients of vernal keratoconjunctivitis (VKC) in a tertiary care center over a period of 6 months from April 2023 to September 2023.
Manpreet Kaur +2 more
doaj +1 more source
Evaluation of Clinical Efficacy and Safety of Prolonged Treatment of Vernal and Atopic Keratoconjunctivitis Using Topical Tacrolimus. [PDF]
Hirota A +4 more
europepmc +1 more source
Pulsed oral corticosteroids for the treatment of vernal and atopic keratoconjunctivitis: a management plan. [PDF]
Fernando P +6 more
europepmc +1 more source
Background: Artificial intelligence (AI) is a promising new technology that has the potential of diagnosing allergic conjunctival diseases (ACDs). However, its development is slowed by the absence of a tailored image database and explainable AI models ...
Michiko Yonehara +22 more
doaj +1 more source
Hampton Addis, Bennie H Jeng Department of Ophthalmology and Visual Sciences, University of Maryland School of Medicine, Baltimore, MD, USA Abstract: Vernal keratoconjunctivitis (VKC) is a chronic allergic conjunctivitis that is most often seen in ...
Jeng BH, Addis H
core
New modalities in the systemic treatment of atopic dermatitis
Atopic dermatitis is a chronic inflammatory skin condition affecting many globally, marked by itching, redness, dryness, and eczematous lesions. Its development is intricate, involving genetics, environment, and immune factors.
Ali, Julia
core
Guidelines for treatment of atopic eczema (atopic dermatitis) Part II
The existing evidence for treatment of atopic eczema (atopic dermatitis, AE) is evaluated using the national standard Appraisal of Guidelines Research and Evaluation.
European Federation of Allergy, +91 more
core +1 more source

